Ganglionic blocker

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A ganglionic blocker is a type of medication which inhibits postganglionic transmission, primariliy by acting as a nicotinic antagonist, for example hexamethonium, pentolinium, mecamylamine, trimetaphan and pempidine.

Ganglionic blockers are used less frequently now than they were in the past, because more selective agents are now available. However, they are still used in some emergency situations, such as aortic dissection.

External links

• Ganglionic+blockers at the US National Library of Medicine Medical Subject Headings (MeSH)